CBI Share Price Performance
₪0.33
-0.05 (-12.47%)
Price ₪0.33
Share Price₪0.33
CBI Community Narratives
There are no narratives available yet.
Recent CBI News & Updates
No updates
Clal Biotechnology Industries Ltd. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.40
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 41.5%
Clal Biotechnology Industries Ltd. Competitors
About CBI
- Founded
- 1998
- Employees
- n/a
- CEO
- WebsiteView website
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel. It operates as a former subsidiary of Clal Industries and Investments Ltd.
Israeli Market Performance
- 7 Days: -0.5%
- 3 Months: 20.0%
- 1 Year: 68.8%
- Year to Date: 28.8%
The market has been flat over the last week. Meanwhile, the market is actually up 69% over the past year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading